RESUMO
INTRODUCTION: Disease subtyping and monitoring are essential for the management of nephrotic syndrome (NS). Although various biomarkers for NS have been reported, their clinical efficacy has not been comprehensively validated in adult Japanese patients. METHODS: The Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study is a nationwide, multicenter, and prospective cohort study in Japan, enrolling adult (≥18 years) patients with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), membranoproliferative glomerulonephritis (MPGN), C3 glomerulopathy (C3G), and lupus nephritis (LN). Baseline clinical information and plasma and urine samples will be collected at the time of immunosuppressive therapy initiation or biopsy. Follow-up data and plasma and urine samples will be collected longitudinally based on the designated protocols. Candidate biomarkers will be measured: CD80, cytotoxic T-lymphocyte antigen 4, and soluble urokinase plasminogen activator receptor for MCD and FSGS; anti-phospholipase A2 receptor and thrombospondin type-1 domain-containing protein 7A antibodies for MN; fragment Ba, C3a, factor I, and properdin for MPGN/C3G; and CD11b, CD16b, and CD163 for LN. Outcomes include complete and partial remission, relapse of proteinuria, a 30% reduction in estimated glomerular filtration rate (eGFR), eGFR decline, and initiation of renal replacement therapy. The diagnostic accuracy and predictive ability for clinical outcomes will be assessed for each biomarker. RESULTS: From April 2019 to April 2023, 365 patients were enrolled: 145, 21, 138, 10, and 51 cases of MCD, FSGS, MN, MPGN/C3G, and LN, respectively. CONCLUSION: This study will provide valuable insights into biomarkers for NS and serve as a biorepository for future studies.
Assuntos
Antígeno B7-1 , Biomarcadores , Síndrome Nefrótica , Humanos , Biomarcadores/sangue , Biomarcadores/urina , Síndrome Nefrótica/urina , Síndrome Nefrótica/sangue , Síndrome Nefrótica/diagnóstico , Estudos Prospectivos , Japão , Glomerulosclerose Segmentar e Focal/urina , Glomerulosclerose Segmentar e Focal/sangue , Glomerulosclerose Segmentar e Focal/diagnóstico , Receptores de Ativador de Plasminogênio Tipo Uroquinase/sangue , Glomerulonefrite Membranosa/urina , Glomerulonefrite Membranosa/sangue , Glomerulonefrite Membranosa/diagnóstico , Adulto , Nefrose Lipoide/urina , Nefrose Lipoide/sangue , Nefrose Lipoide/diagnóstico , Projetos de Pesquisa , Receptores da Fosfolipase A2/imunologia , Trombospondinas/sangue , Glomerulonefrite Membranoproliferativa/sangue , Glomerulonefrite Membranoproliferativa/urina , Glomerulonefrite Membranoproliferativa/diagnóstico , Masculino , Feminino , Nefrite Lúpica/sangue , Nefrite Lúpica/urina , Nefrite Lúpica/diagnóstico , População do Leste AsiáticoRESUMO
To date there are thirteen species validly assigned to the genus Anaerococcus. Most of the species in this genus are anaerobic and of human origin. Anaerococcus urinimassiliensis sp. nov., strain Marseille-P2143T is member of family Peptoniphilaceae, which was isolated from the urine of a 17-year-old boy affected by autoimmune hepatitis and membranoproliferative glomerulonephritis using the culturomic approach. In the current study, a taxono-genomics method was employed to describe this new species. The strain Marseille-P2143T was gram positive cocci with translucent colonies on blood agar. Its genome was 2,189,509 bp long with a 33.5 mol% G + C content and exhibited 98.48% 16S rRNA similarity with Anaerococcus provencensis strain 9,402,080. When Anaerococcus urinomassiliensis strain Marseill-P2143T is compared with closely related species, the values ranged from 71.23% with A. hydrogenalis strain DSM 7454T (NZ_ABXA01000052.1) to 90.64% with A. provencensis strain 9402080T (NZ_HG003688.1). This strain has implemented the repertoire of known bacteria of the human urinary tract.
Assuntos
Firmicutes , Glomerulonefrite Membranoproliferativa , Hepatite Autoimune , Urina/microbiologia , Adolescente , Firmicutes/classificação , Firmicutes/genética , Firmicutes/isolamento & purificação , Glomerulonefrite Membranoproliferativa/microbiologia , Glomerulonefrite Membranoproliferativa/urina , Hepatite Autoimune/microbiologia , Hepatite Autoimune/urina , Humanos , MasculinoRESUMO
Macrophage polarization is a major contributing factor in acute kidney injury (AKI). We aim to determine its biomarker value in differentiating etiologic causes of various intrinsic renal AKI. A total of 205 patients with renal intrinsic AKI were enrolled. Urinary sCD163 was quantified and macrophage subtypes in urine and in renal biopsy were determined. Compared to healthy controls and AKI due to interstitial or tubular injuries (0â¯pg/µmol), urinary sCD163 was markedly higher in glomerulopathy, especially in diffuse proliferative glomerulonephritis (275.5â¯pg/µmol) and significantly correlated with cellular crescent formation. Urine sediment analysis of M1/M2 ratio could differentiate acute tubulointerstitial nephritis (M1/M2â¯>â¯2.35) from crescentic glomerulonephritis (M1/M2â¯<â¯0.27). Urinary sCD163 levels and M2 subtype positively correlated with infiltrated M2 in the glomeruli, whereas urine M1 positively correlated with infiltrated M1 in the interstitium. Of note, urinary sCD163 showed better diagnositic performance in differentiating disease etiologies compared to tradiational urinary biomarkers of AKI (NGAL and KIM-1) and markers of myeloid cells (CD11b) and pan macrophages (CD68). Thus markers of macrophage polarization could be viewed as the noninvasive "liquid biopsy" in the presence of various intrinsic kidney diseases.
Assuntos
Injúria Renal Aguda/urina , Rim/patologia , Macrófagos , Urina/citologia , Injúria Renal Aguda/patologia , Adulto , Contagem de Células , Feminino , Glomerulonefrite/patologia , Glomerulonefrite/urina , Glomerulonefrite Membranoproliferativa/patologia , Glomerulonefrite Membranoproliferativa/urina , Humanos , Necrose Tubular Aguda/patologia , Necrose Tubular Aguda/urina , Masculino , Pessoa de Meia-Idade , Nefrite Intersticial/patologia , Nefrite Intersticial/urina , Microangiopatias Trombóticas/patologia , Microangiopatias Trombóticas/urina , Adulto JovemRESUMO
AIM: To compare the clinical manifestations membranoproliferative glomerulonephritis (MPGN) in its idiopathic variant, lupus nephritis (LN), and C3 glomerulopathy (C3-GP), by comparing them with changes in the complement system. SUBJECTS AND METHODS: The clinic of nephrology followed up 42 patients with different types of MPGN in 2013 to 2015. The study included 35 patients divided into 3 groups: 1) 8 patients with C3-GP, 2) 13 with idiopathic MPGN; 3) 14 with Class IV LN. The investigators studied the blood and urine levels of components and markers for activation of the classical and alternative pathways (C3 and C4, С3а, C5a, CFH, CFB, and CFD) of the terminal complement complex (TCC). RESULTS: The detection rate of C3-GP was 19%. The patients with C3-GP were noted to have the lowest blood concentration of S3 and the highest urinary level of С3а, C5a, TCC, CFH, CFB, and CFD. C3 nephritic factor was detected in 2 patients from the C3-GP (dense deposit disease) group. CONCLUSION: Alternative complement pathway dysregulation caused by genetic or autoimmune factors plays a leading role in the pathogenesis of C3-GP.
Assuntos
Complemento C3/metabolismo , Proteínas do Sistema Complemento/metabolismo , Glomerulonefrite Membranoproliferativa , Nefrite Lúpica , Adulto , Complemento C3/urina , Proteínas do Sistema Complemento/urina , Feminino , Glomerulonefrite Membranoproliferativa/sangue , Glomerulonefrite Membranoproliferativa/urina , Humanos , Nefrite Lúpica/sangue , Nefrite Lúpica/urina , MasculinoRESUMO
BACKGROUND: Several registries and centers have reported the results of renal biopsies from different parts of the world. As there are few data regarding the epidemiology of glomerulonephritis (GN) in South Korea, we conducted this study on renal biopsy findings during the last 20 years from a single center. METHODS: Data for 818 patients who underwent renal biopsy at our center between 1992 and 2011 were collected retrospectively. All kidney specimens were examined with light microscopy (LM) and immunofluorescent microscopy (IF). RESULTS: There were 818 cases of native kidney biopsies. In cases of primary GN, the most frequent type of renal pathology in adults (18-59 years) was mesangial proliferative GN (MsPGN, 34.5%) followed by IgA nephropathy (IgAN, 33.3%) and membranous GN (MGN, 8.8%). Indications in adults (18-59 years) were asymptomatic urinary abnormalities (75.3%) followed by nephrotic syndrome (19.8%) and acute kidney injury (AKI, 3.4%). CONCLUSIONS: Among 818 renal biopsy specimens, MsPGN and IgAN were the most frequent biopsy-proven renal diseases. MGN was the third most common cause of primary GN and lupus nephritis (LN) was the most common secondary glomerular disease. Our data contribute to the epidemiology of renal disease in South Korea.
Assuntos
Glomerulonefrite por IGA/epidemiologia , Glomerulonefrite Membranoproliferativa/epidemiologia , Glomerulonefrite Membranosa/epidemiologia , Rim/patologia , Nefrite Lúpica/epidemiologia , Injúria Renal Aguda/epidemiologia , Injúria Renal Aguda/patologia , Injúria Renal Aguda/urina , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Feminino , Glomerulonefrite por IGA/patologia , Glomerulonefrite por IGA/urina , Glomerulonefrite Membranoproliferativa/patologia , Glomerulonefrite Membranoproliferativa/urina , Glomerulonefrite Membranosa/patologia , Glomerulonefrite Membranosa/urina , Hematúria/epidemiologia , Hematúria/patologia , Hematúria/urina , Humanos , Nefrite Lúpica/patologia , Nefrite Lúpica/urina , Masculino , Microscopia de Fluorescência , Pessoa de Meia-Idade , Síndrome Nefrótica/epidemiologia , Síndrome Nefrótica/patologia , Síndrome Nefrótica/urina , Proteinúria/epidemiologia , Proteinúria/urina , República da Coreia/epidemiologia , Estudos Retrospectivos , Adulto JovemRESUMO
BACKGROUND: Eculizumab may be used to treat C3-glomerulopathy (C3G), a rare but severe glomerular disease. DIAGNOSIS AND TREATMENT: Patients 1, 2 and 3 were diagnosed with nephritic syndrome with alternative complement pathway activation (low C3, C3Nef-positive) and C3G at the age of 9, 13 and 12 years, respectively. Treatment with eculizumab normalized proteinuria within 1, 2 and 7 months, respectively. Proteinuria relapsed when eculizumab was withdrawn, but the re-introduction of eculizumab normalized proteinuria. Patient 4 was diagnosed with C3G at 9 years of age, with progression to end-stage renal disease within 2 years, followed by a first renal transplantation (R-Tx) with early disease recurrence and graft loss within 39 months. After a second R-Tx, she rapidly presented with biological and histological recurrence: therapy with eculizumab was started, with no effect on proteinuria after 5 months, in a complex clinical setting (i.e. association of C3G recurrence, humoral rejection and BK nephritis). Eculizumab was withdrawn due to multiple viral reactivations, but the re-introduction of the drug a few months later enabled a moderate decrease in proteinuria. CONCLUSION: These cases illustrate the efficacy of eculizumab, at least on native kidneys, in paediatric C3G. However, larger international studies are warranted to confirm the benefit and safety of eculizumab therapy.
Assuntos
Anticorpos Monoclonais Humanizados/uso terapêutico , Glomerulonefrite Membranoproliferativa/tratamento farmacológico , Falência Renal Crônica/terapia , Proteinúria/tratamento farmacológico , Adolescente , Criança , Complemento C3/antagonistas & inibidores , Complemento C3/imunologia , Fator Nefrítico do Complemento 3 , Via Alternativa do Complemento/efeitos dos fármacos , Feminino , Glomerulonefrite Membranoproliferativa/complicações , Glomerulonefrite Membranoproliferativa/imunologia , Glomerulonefrite Membranoproliferativa/urina , Rejeição de Enxerto/tratamento farmacológico , Rejeição de Enxerto/imunologia , Humanos , Imunidade Humoral/efeitos dos fármacos , Rim/patologia , Falência Renal Crônica/etiologia , Transplante de Rim/efeitos adversos , Masculino , Uso Off-Label , Recidiva , Resultado do TratamentoAssuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Capilares/patologia , Glomerulonefrite Membranoproliferativa/patologia , Glomérulos Renais/patologia , Linfoma de Células B/patologia , Albuminúria/urina , Anemia/sangue , Anemia/urina , Biópsia , Medula Óssea/patologia , Creatinina/sangue , Diagnóstico Diferencial , Feminino , Glomerulonefrite Membranoproliferativa/sangue , Glomerulonefrite Membranoproliferativa/diagnóstico por imagem , Glomerulonefrite Membranoproliferativa/urina , Humanos , Hipertensão/sangue , Hipertensão/urina , Imuno-Histoquímica , Glomérulos Renais/irrigação sanguínea , Glomérulos Renais/diagnóstico por imagem , Linfócitos/patologia , Linfocitose/sangue , Linfoma de Células B/sangue , Linfoma de Células B/tratamento farmacológico , Linfoma de Células B/urina , Pessoa de Meia-Idade , Esplenomegalia/diagnóstico por imagem , Tomografia Computadorizada por Raios X , UltrassonografiaRESUMO
BACKGROUND: This study aimed to describe the influences of larger physical constitutions including obesity on the amount of urine protein excretion (AUPE) in primary glomerulonephritis. The distinct effects on the AUPE in various types of glomerulonephritis were evaluated. METHODS: Using the database of the Japan Renal Biopsy Registry (J-RBR) from 2007 to 2010, 4060 cases with primary glomerulonephritis including MCNS, FSGS, MN, MPGN, IgAN, and non-IgA were reviewed. The AUPEs were compared between high and low Body Mass Index (BMI) groups, and larger and smaller body surface area (BSA) groups using the indexes of BMI 25.0 kg/m(2) and BSA 1.73 m(2) in all cases and in each histological group. Multivariable analysis was performed to evaluate the predominant contributors to the AUPE. RESULTS: The larger physical constitution groups (BMI ≥25.0 kg/m(2) or BSA ≥1.73 m(2)) had significantly higher AUPEs in all cases with primary glomerulonephritis. When compared in each histological group, the mean AUPEs were significantly higher in the larger physical constitution groups, excluding the FSGS and non-IgA groups. Multiple regression analysis revealed that the significant contributors to the AUPE were BMI and BSA in MCNS and MN, whereas BMI and BSA were not significant and mean blood pressure and serum creatinine were significant in FSGS and non-IgA. CONCLUSION: Larger physical constitutions including obesity had a significant impact on the increase in the AUPE in primary glomerulonephritis, especially in MCNS and MN. However, FSGS and non-IgA were distinct for having blood pressure and renal dysfunction as possibly the major causes of proteinuria.
Assuntos
Índice de Massa Corporal , Superfície Corporal , Glomerulonefrite/urina , Obesidade/urina , Proteinúria/urina , Adulto , Idoso , Feminino , Glomerulonefrite/complicações , Glomerulonefrite/patologia , Glomerulonefrite por IGA/urina , Glomerulonefrite Membranoproliferativa/urina , Glomerulonefrite Membranosa/urina , Glomerulosclerose Segmentar e Focal/urina , Humanos , Japão , Masculino , Pessoa de Meia-Idade , Nefrose Lipoide/urina , Obesidade/complicações , Proteinúria/etiologia , Sistema de RegistrosRESUMO
BACKGROUND: To clarify in vivo neopterin expression within the human kidney and its clinical role as a biomarker for immune complex-mediated mesangial proliferative glomerulonephritis (mesPGN) in children. METHODS: We examined neopterin expression within the kidneys of 14 patients with mesPGN and five patients with minimal changes. We also measured the serum and urinary neopterin levels in fourteen patients with mesPGN and sixteen age-matched healthy controls and correlated the histological findings and clinical features. RESULTS: Neopterin expression was observed within the distal tubular epithelial cells. It was induced within the glomerular endothelial cells and infiltrated CD68-positive macrophages in the glomeruli and interstitial areas. Furthermore, urinary neopterin levels were significantly elevated and positively correlated with histopathological findings and the degree of proteinuria. CONCLUSIONS: These findings indicate that increased urinary neopterin may reflect macrophage activation and active inflammation within the kidney in immune complex-mediated glomerulonephritis. Neopterin may thus represent a useful biomarker of immune complex-mediated glomerulonephritis in the clinical setting.
Assuntos
Glomerulonefrite Membranoproliferativa/urina , Neopterina/urina , Adolescente , Antígenos CD/análise , Antígenos de Diferenciação Mielomonocítica/análise , Biomarcadores/urina , Estudos de Casos e Controles , Criança , Pré-Escolar , Células Endoteliais/química , Feminino , GTP Cicloidrolase/análise , Glomerulonefrite Membranoproliferativa/sangue , Glomerulonefrite Membranoproliferativa/patologia , Hematúria/urina , Humanos , Vasculite por IgA/sangue , Vasculite por IgA/urina , Glomérulos Renais/patologia , Túbulos Renais Distais/química , Macrófagos/química , Masculino , Neopterina/sangue , Proteinúria/urina , Índice de Gravidade de DoençaRESUMO
Steroid-resistant nephrotic syndrome (SRNS) patients are candidates for other alter-native drug regimes, and the non-responsiveness to steroid is more common among glomerulo-nephritides other than minimal change disease. Without performing biopsy and proper renal histology, progression of the disease cannot be assessed. Fractional excretion of magnesium (FE Mg) has been found to correlate directly with various renal histologies. The aim of this study is to evaluate the relationship of FE Mg in children with the histological pattern in SRNS. In this prospective observational study, 40 children of nephrotic syndrome, both with the first episode as well as relapse, aged 1-12 years were included in the study. Of them, 20 were steroid-responsive cases and 20 were steroid-resistant cases. FE Mg was determined in all the patients and renal histology was performed in the steroid-resistant cases. A correlation was found between FE Mg and renal histology. Data were analyzed in SPSS program version-16. Comparison of two groups was performed by the Fisher exact test and unpaired t test. P-value less than 0.05 were considered to be significant. The results of histo-pathology showed that the mean difference in FE Mg was significant (P <0.001), as FE Mg was 7.0 ± 2.3% in mesangiocapillary glomerulonephritis, 6.9 ± 1.3% in focal segmental glomerulosclerosis, 4.7 ± 0.6% in immunoglobulin M nephropathy, 4.5 ± 1.2% in focal segmental proliferative glomerulo-nephritis, 4.4 ± 1.6% in minimal change disease, 4.2 ± 0.4% in diffuse mesangial proliferative glome-rulonephritis and 3.8 ± 1.3% in mesangial proliferative glomerulonephritis. There was a statistically significant difference between FE Mg in steroid-resistant nephrotic syndrome (4.9 ± 1.9) and steroid-responsive syndrome (1.2 ± 0.3). FE Mg is a simple, minimally invasive screening marker for SRNS, and is an early predictor of clinical outcome. It can be considered as an initial investigation where biopsy cannot be performed or indications are not clear.
Assuntos
Rim/efeitos dos fármacos , Magnésio/urina , Síndrome Nefrótica/congênito , Esteroides/uso terapêutico , Biomarcadores/urina , Biópsia , Criança , Pré-Escolar , Feminino , Glomerulonefrite Membranoproliferativa/diagnóstico , Glomerulonefrite Membranoproliferativa/tratamento farmacológico , Glomerulonefrite Membranoproliferativa/urina , Glomerulosclerose Segmentar e Focal/diagnóstico , Glomerulosclerose Segmentar e Focal/tratamento farmacológico , Glomerulosclerose Segmentar e Focal/urina , Humanos , Lactente , Rim/metabolismo , Rim/patologia , Masculino , Nefrose Lipoide/diagnóstico , Nefrose Lipoide/tratamento farmacológico , Nefrose Lipoide/urina , Síndrome Nefrótica/diagnóstico , Síndrome Nefrótica/tratamento farmacológico , Síndrome Nefrótica/urina , Valor Preditivo dos Testes , Estudos Prospectivos , Recidiva , Índice de Gravidade de Doença , Fatores de Tempo , Resultado do Tratamento , UrináliseRESUMO
AIM: The aim of the present study was to assess whether laboratory investigations have predictional values for histopathological diagnosis of glomerulonephritis before performing renal biopsy. METHODS: The study enrolled 452 patients, who underwent kidney biopsy and were examined retrospectively; 128 patients with the histopathological diagnosis of glomerulonephritis were included in the study. Serum CRP, albumin, uric acid levels, 24 hour urine protein presence, leucocyte count, C3, C4, IgG, IgA and IgM levels were assessed. RESULTS: The most common diagnosis of glomerulonephritis was IgAN with the percentage of 29.7% within the groups. Male gender was predominant except lupus group. Only the ones with crescentic glomerulonephritis had higher CRP levels. In 20% of patients with IgAN, in 8.3% of the ones with MN, in 35% of crescentic group, in 42% of FSGS group, in 30% of patients with MPGN and in 33% of the ones with lupus nephritis uric acid levels were found as elevated. In IgAN, FSGS and lupus nephritis normoalbuminemia and nephritic proteinuria, in MN and crescentic glomerulonephritis hypoalbuminemia, nephrotic proteinuria, in MPGN hypoalbuminemia, nephritic proteinuria were established. Serum Ig G levels were lower in MN and MPGN. Serum IgA levels were found as elevated in IgAN. Serum C4 levels were found as lower in lupus nephritis and MPGN. CONCLUSION: In patients admitted in clinical picture of glomerulopathy, since measurements of serum CRP, albumin, uric acid, C3, C4,IgG, IgA, IgM levels, leucocyte count and 24 hour urine protein amount can lead to predict the histopathological diagnosis, their significance in routine investigations has been suggested also in our study.
Assuntos
Proteína C-Reativa/análise , Glomerulonefrite/sangue , Glomerulonefrite/patologia , Rim/patologia , Albumina Sérica/análise , Ácido Úrico/sangue , Análise de Variância , Biópsia , Complemento C3/análise , Complemento C4/análise , Feminino , Glomerulonefrite/urina , Glomerulonefrite por IGA/sangue , Glomerulonefrite por IGA/patologia , Glomerulonefrite por IGA/urina , Glomerulonefrite Membranoproliferativa/sangue , Glomerulonefrite Membranoproliferativa/patologia , Glomerulonefrite Membranoproliferativa/urina , Glomerulosclerose Segmentar e Focal/sangue , Glomerulosclerose Segmentar e Focal/patologia , Glomerulosclerose Segmentar e Focal/urina , Humanos , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Contagem de Leucócitos , Nefrite Lúpica/sangue , Nefrite Lúpica/patologia , Nefrite Lúpica/urina , Masculino , Proteinúria/diagnóstico , Estudos RetrospectivosAssuntos
Imunoglobulina A , Cadeias lambda de Imunoglobulina , Idoso , Glomerulonefrite Membranoproliferativa/sangue , Glomerulonefrite Membranoproliferativa/tratamento farmacológico , Glomerulonefrite Membranoproliferativa/etiologia , Glomerulonefrite Membranoproliferativa/patologia , Glomerulonefrite Membranoproliferativa/urina , Humanos , Masculino , Pessoa de Meia-Idade , Paraproteinemias/sangue , Paraproteinemias/complicações , Paraproteinemias/tratamento farmacológico , Paraproteinemias/patologia , Paraproteinemias/urinaRESUMO
BACKGROUND: Several renal histopathological features, including mesangial hypercellularity, glomerulosclerosis, tubular atrophy and interstitial fibrosis, are considered to be independent predictors of end-stage renal failure in patients with glomerular diseases. Mesangial proliferative glomerulonephritis (MesPGN) is characterized by proliferations of mesangial cells with increase in mesangial matrix and/or deposits in mesangial region. The purpose of this study is to determine the association between urinary protein markers measured at the same time as renal biopsy and the severity of renal histological lesions in children with MesPGN, and to evaluate whether these markers could serve as predictors of severe renal histological lesions in this population. METHODS: Ninety-eight children with MesPGN (40 with IgA nephropathy, 37 with IgM nephropathy, and 21 with MesPGN without IgA/IgM deposition) were enrolled. Urinary level of IgG, albumin, transferrin, α1-microglobulin, ß2-microglobulin and N-acetyl-ß-glucosaminidase from a morning sample before biopsy was measured.The scores of mesangial hypercellularity, glomerulosclerosis, and tubule-interstitial damage were used to semi-quantitatively evaluate renal histological lesions. RESULTS: The urine proteins, as independent factors associated with severe mesangial cellularity (> 5 mesangial cells/ mesangial area) were transferrin, albumin, α1-microglobulin, IgG and 24-hour total protein, with severe glomerulosclerosis (≥ 10 % glomeruli showing segmental adhesions or sclerosis) were transferrin and 24-hour total protein, and with severe tubule-interstitial damage (focal or diffuse tubular and interstitial lesions) were transferrin and N-acetyl-ß-glucosaminidase. Urinary transferrin achieved the area under-the-receiver-operating-characteristic curve (AUC) of 0.86 and 0.82, respectively, for predicting severe mesangial cellularity and glomerulosclerosis. Urinary N-acetyl-ß-glucosaminidase achieved the highest AUC of 0.82 for predicting severe tubule-interstitial damage. The combination of urinary protein markers, however, did not improve the predictability for renal histological lesions. CONCLUSIONS: Urinary protein markers are useful to predict the severity of renal histological lesions in children with MesPGN, which suggests that urinary proteins might be useful to predict the development and progression of renal histological lesions, and assist in evaluating the outcome and prognosis in children with MesPGN as non-invasive and easily repeatable indicators on the follow-up examination.
Assuntos
Glomerulonefrite Membranoproliferativa/patologia , Glomerulonefrite Membranoproliferativa/urina , Glomerulosclerose Segmentar e Focal/patologia , Glomerulosclerose Segmentar e Focal/urina , Túbulos Renais/patologia , Células Mesangiais/patologia , Acetilglucosaminidase/urina , Adolescente , Albuminúria/urina , alfa-Globulinas/urina , Análise de Variância , Área Sob a Curva , Biomarcadores/urina , Biópsia , Criança , Pré-Escolar , Feminino , Glomerulonefrite Membranoproliferativa/complicações , Glomerulonefrite Membranoproliferativa/metabolismo , Glomerulosclerose Segmentar e Focal/complicações , Humanos , Imunoglobulina A/metabolismo , Imunoglobulina G/urina , Imunoglobulina M/metabolismo , Masculino , Valor Preditivo dos Testes , Curva ROC , Índice de Gravidade de Doença , Transferrina/urina , Microglobulina beta-2/urinaRESUMO
INTRODUCTION: Systemic lupus erythematosus (SLE or lupus) is a chronic autoimmune disease, and kidney involvement with SLE, a.k.a. lupus nephritis (LN), is a frequent and severe complication of SLE that increases patient morbidity and mortality. About 50% of patients with SLE encounter renal abnormalities which, if left untreated, can lead to end-stage renal disease. Kidney biopsy is considered the criterion standard for diagnosis and staging of LN using the International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification, which was developed to help predict renal outcomes and assist with medical decision-making. However, kidney biopsy-based classification of LN is highly invasive and impractical for real-time monitoring of LN status. Here, nuclear magnetic resonance (NMR) spectroscopy-based metabolic profiling was used to identify urinary metabolites that discriminated between proliferative and pure membranous LN as defined by the ISN/RPS classification, and between LN and primary focal segmental glomerulosclerosis (FSGS). METHODS: Metabolic profiling was conducted using urine samples of patients with proliferative LN without membranous features (Class III/IV; n = 7) or pure membranous LN (Class V; n = 7). Patients with primary FSGS and proteinuria (n = 10) served as disease controls. For each patient, demographic information and clinical data was obtained and a random urine sample collected to measure NMR spectra. Data and sample collection for patients with LN occurred around the time of kidney biopsy. Metabolic profiling analysis was done by visual inspection and principal component analysis. RESULTS: Urinary citrate levels were 8-fold lower in Class V LN compared to Class III/IV patients, who had normal levels of urinary citrate (P < 0.05). Class III/IV LN patients had > 10-fold lower levels of urinary taurine compared to Class V patients, who had mostly normal levels (P < 0.01). Class V LN patients had normal urinary hippurate levels compared to FSGS patients, who completely lacked urinary hippurate (P < 0.001). CONCLUSIONS: This pilot study indicated differences in urinary metabolites between proliferative LN and pure membranous LN patients, and between LN and FSGS patients. If confirmed in larger studies, these urine metabolites may serve as biomarkers to help discriminate between different classes of LN, and between LN and FSGS.
Assuntos
Glomerulonefrite Membranoproliferativa/metabolismo , Glomerulonefrite Membranosa/metabolismo , Lúpus Eritematoso Sistêmico/metabolismo , Metabolômica/métodos , Ácido Cítrico/urina , Diagnóstico Diferencial , Feminino , Glomerulonefrite Membranoproliferativa/diagnóstico , Glomerulonefrite Membranoproliferativa/urina , Glomerulonefrite Membranosa/diagnóstico , Glomerulonefrite Membranosa/urina , Hipuratos/urina , Humanos , Lúpus Eritematoso Sistêmico/diagnóstico , Lúpus Eritematoso Sistêmico/urina , Espectroscopia de Ressonância Magnética , Masculino , Projetos Piloto , Análise de Componente Principal , Curva ROC , Taurina/urinaRESUMO
This article presents the data of 118 patients (77 men and 41 women) with mesangial proliferative glomerulonephritis, aged 22-70 years. It is concluded that the rate of progression and severity of chronic glomerulonephritis, even within the same morphological form, is determined by age.
Assuntos
Envelhecimento/patologia , Glomerulonefrite Membranoproliferativa/patologia , Células Mesangiais/patologia , Adulto , Idoso , Envelhecimento/sangue , Envelhecimento/urina , Biópsia por Agulha , Estudos de Casos e Controles , Proliferação de Células , Interpretação Estatística de Dados , Feminino , Glomerulonefrite Membranoproliferativa/sangue , Glomerulonefrite Membranoproliferativa/urina , Humanos , Testes de Função Renal , Masculino , Pessoa de Meia-Idade , Adulto JovemRESUMO
Homozygous complement C4B deficiency is described in a Southern European young female patient with Membranoproliferative Glomerulonephritis (MPGN) type III characterized by renal biopsies with strong complement C4 and IgG deposits. Low C4 levels were independent of clinical evolution or type of immunosuppression and were found in three other family members without renal disease or infections. HLA typing revealed that the patient has homozygous A*02, Cw*06, B*50 at the class I region, and DRB1*08 and DQB1*03 at the class II region. Genotypic and phenotypic studies demonstrated that the patient has homozygous monomodular RCCX in the HLA class III region, with single long C4A genes coding for C4A3 and complete C4B deficiency. Her father, mother, son and niece have heterozygous C4B deficiency. The patient's deceased brother had a history of Henoch-Schönlein Purpura (HSP), an immune complex-mediated proliferative glomerulonephritis. These findings challenge the putative pathophysiological roles of C4A and C4B and underscore the need to perform functional assays, C4 allotyping and genotyping on patients with persistently low serum levels of a classical pathway complement component and glomerulopathy associated with immune deposits.
Assuntos
Complemento C4b/deficiência , Complemento C4b/genética , Glomerulonefrite Membranoproliferativa/genética , Adulto , Complemento C4a/genética , Complemento C4b/metabolismo , Creatinina/urina , Feminino , Genótipo , Glomerulonefrite Membranoproliferativa/sangue , Glomerulonefrite Membranoproliferativa/tratamento farmacológico , Glomerulonefrite Membranoproliferativa/patologia , Glomerulonefrite Membranoproliferativa/urina , Antígenos HLA/genética , Haplótipos/genética , Heterozigoto , Homozigoto , Humanos , Rim/patologia , Síndrome Nefrótica/sangue , Síndrome Nefrótica/patologia , Síndrome Nefrótica/urina , Linhagem , Polimorfismo de Fragmento de Restrição/genética , Proteinúria/urina , Esteroide 21-Hidroxilase/genética , Tenascina/genéticaRESUMO
BACKGROUND: Recent studies showed that serum and urinary neutrophil gelatinase-associated lipocalin (NGAL) represents a novel, sensitive, specific biomarker for early detection of acute kidney injury. However, the clinical significance of measuring serum and urinary NGAL on chronic renal diseases remains unclear. METHODS: In this study, we measured serum and urinary NGAL levels in patients with several common pediatric renal diseases such as renal dysfunction (estimated glomerular filtration rate < 90 mL/min/1.73 m(2)), proliferative glomerulonephritis, steroid-resistant and steroid-sensitive nephrotic syndrome, and tubular dysfunction. RESULTS: Urinary NGAL level was significantly increased compared with the control in all of these disease groups except in patients with a remission stage of steroid-sensitive nephrotic syndrome, although a significant increase in serum NGAL level was observed in the renal dysfunction group only. Both serum and urinary NGAL levels showed significant inverse correlations with an estimated glomerular filtration rate in the analysis with total subjects, and also in the analysis with the renal dysfunction group in urinary NGAL. In proteinuric patients, the extent of proteinuria significantly correlated with urinary NGAL level. In patients with tubular dysfunction, the increase of urinary NGAL level was remarkable compared with the other disease groups. CONCLUSION: These results indicated that urinary NGAL level is a better biomarker for chronic renal diseases in children than serum NGAL level, although multiple pathological mechanisms should be considered in evaluating these NGAL values.
Assuntos
Proteínas de Fase Aguda/urina , Glomerulonefrite/diagnóstico , Lipocalinas/sangue , Lipocalinas/urina , Síndrome Nefrótica/diagnóstico , Proteínas Proto-Oncogênicas/sangue , Proteínas Proto-Oncogênicas/urina , Insuficiência Renal Crônica/diagnóstico , Adolescente , Adulto , Biomarcadores/sangue , Biomarcadores/urina , Criança , Pré-Escolar , Taxa de Filtração Glomerular , Glomerulonefrite/sangue , Glomerulonefrite/urina , Glomerulonefrite Membranoproliferativa/sangue , Glomerulonefrite Membranoproliferativa/diagnóstico , Glomerulonefrite Membranoproliferativa/urina , Humanos , Lactente , Lipocalina-2 , Masculino , Síndrome Nefrótica/sangue , Síndrome Nefrótica/urina , Insuficiência Renal Crônica/sangue , Insuficiência Renal Crônica/urina , Adulto JovemRESUMO
Bernese Mountain dogs (BMDs) are prone to develop a familial glomerulonephropathy and a pathogenic role of Borrelia burgdorferi sensu lato in this disease has been suspected. Glomerular disease in many affected dogs is clinically inapparent and proteinuria is found incidentally. In this study, urine protein excretion was evaluated in 122 clinically healthy BMDs and 55 controls. The seroprevalence of B. burgdorferi in BMDs was 57%, compared to 16% in controls. There were no significant differences in the occurrence of positive dipstick results, microalbuminuria, urine protein-to-urine creatinine ratio or abnormal urine protein pattern (determined by sodium dodecyl sulphate agarose gel electrophoresis) between BMDs and controls and BMDs with and without antibodies against B. burgdorferi. It was concluded that antibodies against B. burgdorferi are not associated with proteinuria as an early sign of renal disease in BMDs.
Assuntos
Grupo Borrelia Burgdorferi/imunologia , Doenças do Cão/urina , Glomerulonefrite Membranoproliferativa/veterinária , Doença de Lyme/veterinária , Proteinúria/veterinária , Animais , Anticorpos Antibacterianos/sangue , Grupo Borrelia Burgdorferi/isolamento & purificação , Doenças do Cão/genética , Doenças do Cão/microbiologia , Cães , Feminino , Glomerulonefrite Membranoproliferativa/genética , Glomerulonefrite Membranoproliferativa/microbiologia , Glomerulonefrite Membranoproliferativa/urina , Doença de Lyme/complicações , Doença de Lyme/urina , Masculino , Linhagem , Proteinúria/diagnósticoRESUMO
The differential roles of circulating and intrarenal renin-angiotensin system (RAS) in glomerulonephritis have not been elucidated. In this study, we investigated the levels of circulating and intrarenal RAS activity and urinary angiotensinogen (AGT) excretion in anti-thymocyte serum (ATS) nephritis induced by an ATS injection (ATS group). The effect of olmesartan, an angiotensin II (ANG II) type 1 receptor blocker (ARB), on the development of nephritis was also examined (ATS+ARB group). In addition, the rats received a saline injection instead of ATS (control group). Mesangial proliferation with transient proteinuria, which peaked at day 7, was significantly increased in the ATS group compared with the control group. The levels of glomerular AGT mRNA, intrarenal ANG II, and urinary AGT excretion in the ATS group were increased significantly at day 7 compared with the control group. Administration of olmesartan (ATS+ARB group) significantly decreased the levels of renal lesions, proteinuria, and intrarenal RAS activity compared with the ATS group. In addition, the levels of urinary AGT excretion correlated with the levels of glomerular damage, urinary protein excretion, and immunoreactivity for AGT and ANG II in kidney. On the other hand, plasma renin activity was significantly lower in the ATS group compared with the control group and significantly higher in the ATS+ARB group than in the ATS group. These data suggest that an increase in kidney-specific RAS activity, which parallels urinary AGT excretion, plays an important role in the development of ATS nephritis.
Assuntos
Angiotensinogênio/urina , Soro Antilinfocitário/farmacologia , Glomerulonefrite Membranoproliferativa/fisiopatologia , Sistema Renina-Angiotensina/fisiologia , Angiotensina II/sangue , Angiotensina II/metabolismo , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Angiotensinogênio/genética , Angiotensinogênio/metabolismo , Animais , Pressão Sanguínea/fisiologia , Expressão Gênica/efeitos dos fármacos , Glomerulonefrite Membranoproliferativa/patologia , Glomerulonefrite Membranoproliferativa/urina , Imidazóis/farmacologia , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Masculino , Proteinúria/urina , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Renina/sangue , Tetrazóis/farmacologiaRESUMO
BACKGROUND: The detection of viable podocytes in the urine of patients with proteinuric diseases has been described as a non-invasive method to monitor disease activity. Most of the published studies use podocalyxin (PDX) as a podocyte specific marker. METHODS: We examined the excretion of viable PDX-positive cells in a random set of spot urine from patients with biopsy-proven focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MGN) or membranoproliferative glomerulonephritis (MPGN) and characterized the excreted cells for podocyte and parietal epithelia markers as well as for proliferation activity. RESULTS: We found that untreated patients with active disease excrete high numbers of PDX-positive cells in their urine. In contrast to that we were not able to detect significant amounts of PDX-positive cells in the urine of patients with active minimal change disease (MCD) and patients with FSGS or MGN in full remission. When we further characterized the cells we rarely detected expression of podocyte specific markers in the PDX-positive cells, but at least 50% of the PDX-positive cells were double positive for cytokeratin (CK8-18). Immunohistochemistry of the corresponding renal biopsies showed that 100% of podocytes and parietal cells stained positive for PDX. Semiquantitative analysis revealed that 45% of parietal cells were positive for CK8-18 and 100% of proximal tubular cells. No cells of the glomerular epithelial layer stained positive for CK8-18. CONCLUSIONS: PDX-positive cells are lost in the urine in disease states that require podocyte regeneration and are a useful non-invasive marker for glomerular disease activity. These cells are possibly derived from the parietal epithelial layer.